Position in PTGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,977,760
+$1,541,804 QoQ
Shares Held
28,252
+71.8% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 94.44641087356648.ToString("F0")%
Shared 0.ToString("F0")%
None 5.553589126433526.ToString("F0")%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pathstone Holdings, LLC holds $81,066,919 across 49 Biotechnology names. PTGX ranks #4 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
44,262 | $19,764,751 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,912 | $12,294,246 | |
| 3 | INSM |
INSMED Inc
|
27,249 | $4,455,756 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
This page
|
28,252 | $2,977,760 | |
| 5 | CYTK |
Cytokinetics Inc
|
44,516 | $2,934,049 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
5,457 | $2,856,575 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
13,947 | $2,636,679 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
32,835 | $2,465,579 |
All Filings in PTGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,977,760 | 28,252 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,435,956 | 16,441 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $887,637 | 13,362 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $452,936 | 8,195 | Shares | Defined | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||